INFORMATION FOR
News
For the past 25 years, Women's Health Research at Yale has been investigating conditions of high morbidity and mortality in women and understanding sex and gender differences that affect health outcomes.
After discovering a specific lupus antibody that can penetrate cancer cells and, with a grant from Women's Health Research at Yale, showing it makes cancer cells vulnerable to standard treatments, Dr. Peter Glazer and his colleagues are moving a treatment to clinical trials.
Across the country, it’s becoming clearer every day: We must study the health of women. We must study the influence of sex-and-gender differences on health. And it’s time for all aspects of medical research and practice to embrace this change.
WHRY Director Carolyn M. Mazure discusses how we are at a critical point, and the scientific community needs to decide if it will embrace true transformational change in science.
Women’s Health Research at Yale (WHRY) is funding a study to explain how well-known genetic mutations can lead to ovarian cancer.
Women’s Health Research at Yale (WHRY), a self-supporting center within Yale School of Medicine, will celebrate its 20th anniversary in February. With data developed through $5 million in WHRY grants to date, Yale scientists have gone on to secure $95 million in external grants to further their research into women’s health.
When it comes to life-threatening diseases, people understandably want to maximize their chances for survival. So when considering the best practices to check for breast cancer, it makes intuitive sense that doctors and patients would prefer to screen early and often.
While guidelines offer slight disagreements about whether women should begin annual screening mammograms at a certain age, experts stress that recommendations have more in common than not.
In an interview, Rachel Perry, PhD, discusses the link between insulin and cancer, a surprising finding in her research, and the future of precision medicine for metabolism-related cancers.
Smilow Shares with Primary Care: Breast Cancer
Eric Winer, MD, the director of Yale Cancer Center and president and physician-in-chief of Smilow Cancer Hospital in New Haven, Connecticut, tells SELF that there’s not quite a consensus on when cis women and people assigned female at birth should begin getting mammograms.
Monica G. Valero, MD, assistant professor of surgery (oncology) and director of the Hispanic Breast Cancer Program, has received a prestigious one-year pilot grant from the American Cancer Society (ACS) to advance breast cancer care among the Hispanic population. The prestigious award affirms the Department of Surgery’s commitment to tackling health inequities on a national scale and locally.
No matter how metastatic breast cancer affects your love life, intimacy with your partner can still be meaningful and enjoyable.
Smilow Cancer Hospital, in partnership with the Norma Pfriem Breast Center, has opened a new patient care location in Bridgeport, CT to provide residents in the greater Bridgeport area with convenient access to Smilow Cancer Hospital specialty breast surgical care and expertise.
The Center for Breast Cancer at Smilow Cancer Hospital and Yale Cancer Center provides coordinated, state-of-the-art care for patients with benign and malignant diseases of the breast.
The Prudence Stiltor Crozier Breast Surgical Oncology Annual Lectureship and Resource Fund, to be guided by Mehra Goldhan, MD, MBA, aims to educate the next generation of breast surgeons.
Ellie Proussaloglou, MD, assistant professor of surgery (breast surgical oncology) discusses her fellowship at Yale and the transition from fellowship to being an attending.
Maryam Lustberg, director of the Center for Breast Cancer and chief of breast medical oncology at Yale Cancer Center and Smilow Cancer Hospital, says some promising advancements are already underway.
Researchers have revealed significant differences in the genetic characteristics of HER2-low advanced breast cancers, which may lead to the development of novel therapeutics for patients, according to recent findings presented at the 2023 San Antonio Breast Cancer Symposium.
New research illustrates remarkably lower use of immediate breast reconstruction in older women of Asian descent.